4 results about "Fatty acid biosynthesis" patented technology

The present disclosure relates to an antiviral pharmaceutical composition including an estrogen-related receptor γ (ERRγ) inhibitor as an active ingredient. According to embodiments of the present disclosure, an antiviral pharmaceutical composition containing an ERRγ inhibitor as an active ingredient has antiviral effects. In particular, the antiviral pharmaceutical composition is effective in preventing or treating RNA virus infections. Specifically, the ERRγ inhibitor, especially an ERRγ inverse agonist, may exhibit broad-spectrum antiviral effects by inhibiting ERRγ activity in RNA virus-infected cells, thereby blocking fatty acid biosynthesis mediated by sterol regulatory element-binding protein 1c (SREBP1c).

The application provides application of a LuPDH-E1beta1 gene in regulating plant fatty acid synthesis, and after overexpression of the LuPDH-E1beta1 gene in plants, the amount of plant fatty acid synthesis can be increased. The application also provides application of the LuPDH-E1beta1 gene in regulating plant salt tolerance and drought resistance, and after overexpression of the LuPDH-E1beta1 gene in plants, the salt tolerance and drought resistance of a PDH-E1beta1 gene deletion plant can be increased. Through exploration of the function of the LuPDH-E1beta1 gene in plant seed oil metabolism and response to abiotic stress, the application of the LuPDH-E1beta1 gene in regulating plant fatty acid synthesis and salt tolerance and drought resistance is given, and a blank in the application of the LuPDH-E1beta1 gene in genetic engineering is filled.

Methods of treating NASH / MASH comprising administering a fatty acid synthesis (FASN) inhibitor and compositions for treating the same are provided herein.

The application discloses modified potato resistant starch and application thereof in set yogurt, and comprises the following steps: adding chitosan oligosaccharide and zinc salt into potato PRS3 starch milk, mixing and treating, reacting with leucine-glycine dipeptide to obtain composite modified potato PRS3 starch; pre-gelatinizing the composite modified potato PRS3 starch, mixing with milk, mixing, homogenizing, sterilizing, inoculating and fermenting, and post-ripening to prepare set yogurt. 2+ The chitosan oligosaccharide-Zn 2+ and leucine-glycine dipeptide composite modified potato PRS3 starch forms a reversible three-dimensional coordination network and hydrophobic interaction, significantly improves transparency, freeze-thaw stability and resistance retention rate, and enhances the adsorption and combination capacity of milk protein and milk fat. The set yogurt has good gel strength, texture characteristics and sensory quality, effectively promotes the proliferation of probiotics, improves the coagulation efficiency, prevents whey separation and promotes the synthesis of intestinal short-chain fatty acids, and improves intestinal health.